Please Wait.....
Report
Immunoassay Market By Product (Reagents and Kits, Analyzers), By Technology (ELISA, Chemiluminescence Immunoassay, Immunofluorescence assay, Rapid Test, ELISpot, Western Blotting, Others) By Specimen (Infectious Diseases, Endocrinology, Oncology, Bone and Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others) By End user (Hospitals and Clinics, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Blood Banks, Research and Academic Laboratories, Home Care Settings) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 216 Pages I Allied Market Research
Immunoassay Market
The immunoassay market was valued at $35.0 billion in 2023 and is projected to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.
Immunoassay is a bioanalytical method that detects and quantifies the presence of proteins or antigens in a sample. The basic principle of immunoassay relies on the interaction between an antibody and a target molecule, which results in the generation of a quantifiable signal, such as fluorescence or color change. The method finds applications in pharmaceutical research, medical diagnostics,and environmental monitoring. The high specificity & sensitivityof the method is pivotal in monitoring drug levels, diagnosing diseases, screening for infectious agents, and detecting biomarkers.
Rise in the prevalence of infectious and chronic diseases is a significant driver of the immunoassay market. In addition, surge in investments in the pharmaceutical & biotechnology infrastructure has led to the expansion in infrastructure, thereby boosting the demand for immunoassay components for diverse purposes such as clinical trials, biomarker analysis, and drug discovery. Trends in the immunoassay market evolve constantly, enhancing the sensitivity and specificity of the tests. The integration of robotics and automation is acquiring traction in the market as it is enhancing productivity and helping to reduce human error in the laboratories.
However, procuring reliable instruments and authentic samples to critical for obtaining successful results. The acquisition of such trustworthy components is a challenging task owing to less retailers in the industry, thereby restraining the development of the immunoassay market. On the contrary, manufacturers of immunoassay systems strive to introduce innovative products, thereby presenting lucrative opportunities for market development. Next generation of immunoassay systems is projected to leverage the benefits of microfluidics and nanotechnology for achieving instant & accurate results.
Segment Review
Theimmunoassay marketis segmented into product, technology, specimen, end user, and region. On the basis of product, the market is bifurcated into reagents & kits and analyzers. As per technology, it is classified into ELISA, chemiluminescence immunoassay, immunofluorescence assay, rapid test, ELISpot, western blotting, and others. According to specimen, it is categorized into infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, blood screening, autoimmune disorders, allergy diagnostics, toxicology, newborn screening, and others. By end user, it is divided into hospitals & clinics, clinical laboratories, pharmaceutical & biotechnology companies, blood banks, research & academic laboratories, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
As per technology, the ELISA segment generated the highest revenue in 2023.
According to specimen, the blood screening segment was the highest shareholder in 2023.
By end user, the hospitals & clinics segment acquired high market stakes in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players operating in the global immunoassay market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Siemens Healthineers, DiaSorin S.p.A., Sysmex Corporation, BioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Merck kGaA. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Product
- Reagents and Kits
- Analyzers
By Technology
- ELISA
- Chemiluminescence Immunoassay
- Immunofluorescence assay
- Rapid Test
- ELISpot
- Western Blotting
- Others
By Specimen
- Infectious Diseases
- Endocrinology
- Oncology
- Bone and Mineral Disorders
- Cardiology
- Blood Screening
- Autoimmune Disorders
- Allergy Diagnostics
- Toxicology
- Newborn Screening
- Others
By End User
- Hospitals and Clinics
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Blood Banks
- Research and Academic Laboratories
- Home Care Settings
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Abbott Laboratories
- Siemens Healthineers
- DiaSorin S.p.A.
- Sysmex Corporation
- BioMerieux SA
- Ortho Clinical Diagnostics
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Merck kGaA
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: URINALYSIS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Instruments
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Consumables
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: URINALYSIS MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Disease Screening
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Pregnancy Fertility Testing
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: URINALYSIS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Clinical Laboratories
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Home Care
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: URINALYSIS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Urinalysis Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Urinalysis Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Urinalysis Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Urinalysis Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Urinalysis Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Urinalysis Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Urinalysis Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Urinalysis Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Urinalysis Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Urinalysis Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Urinalysis Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Urinalysis Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Urinalysis Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Urinalysis Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Urinalysis Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Urinalysis Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Urinalysis Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Urinalysis Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Urinalysis Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Sysmex Corporation
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Siemens Healthcare GmbH
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. ACON Laboratories, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Arkray Inc
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. F. Hoffmann-La Roche Ltd.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Quidel Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Thermo Fisher Scientific Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Bio-Rad Laboratories, Inc.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. IMMUNOASSAY MARKET FOR REAGENTS AND KITS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. IMMUNOASSAY MARKET FOR ANALYZERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 5. IMMUNOASSAY MARKET FOR ELISA, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. IMMUNOASSAY MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. IMMUNOASSAY MARKET FOR IMMUNOFLUORESCENCE ASSAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. IMMUNOASSAY MARKET FOR RAPID TEST, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. IMMUNOASSAY MARKET FOR ELISPOT, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. IMMUNOASSAY MARKET FOR WESTERN BLOTTING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. IMMUNOASSAY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. GLOBAL IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 13. IMMUNOASSAY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. IMMUNOASSAY MARKET FOR ENDOCRINOLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. IMMUNOASSAY MARKET FOR ONCOLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. IMMUNOASSAY MARKET FOR BONE AND MINERAL DISORDERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 17. IMMUNOASSAY MARKET FOR CARDIOLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 18. IMMUNOASSAY MARKET FOR BLOOD SCREENING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 19. IMMUNOASSAY MARKET FOR AUTOIMMUNE DISORDERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 20. IMMUNOASSAY MARKET FOR ALLERGY DIAGNOSTICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 21. IMMUNOASSAY MARKET FOR TOXICOLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 22. IMMUNOASSAY MARKET FOR NEWBORN SCREENING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 23. IMMUNOASSAY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 24. GLOBAL IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 25. IMMUNOASSAY MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 26. IMMUNOASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 27. IMMUNOASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 28. IMMUNOASSAY MARKET FOR BLOOD BANKS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 29. IMMUNOASSAY MARKET FOR RESEARCH AND ACADEMIC LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 30. IMMUNOASSAY MARKET FOR HOME CARE SETTINGS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 31. IMMUNOASSAY MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 32. NORTH AMERICA IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 33. NORTH AMERICA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 34. NORTH AMERICA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 35. NORTH AMERICA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 36. NORTH AMERICA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. U.S. IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 38. U.S. IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 39. U.S. IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 40. U.S. IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. CANADA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 42. CANADA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 43. CANADA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 44. CANADA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. MEXICO IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 46. MEXICO IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 47. MEXICO IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 48. MEXICO IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. EUROPE IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. EUROPE IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 51. EUROPE IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 52. EUROPE IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 53. EUROPE IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. FRANCE IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 55. FRANCE IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 56. FRANCE IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 57. FRANCE IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. GERMANY IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 59. GERMANY IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 60. GERMANY IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 61. GERMANY IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. ITALY IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 63. ITALY IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 64. ITALY IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 65. ITALY IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 66. SPAIN IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 67. SPAIN IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 68. SPAIN IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 69. SPAIN IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. UK IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 71. UK IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 72. UK IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 73. UK IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. REST OF EUROPE IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 75. REST OF EUROPE IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 76. REST OF EUROPE IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 77. REST OF EUROPE IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 78. ASIA-PACIFIC IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 79. ASIA-PACIFIC IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 80. ASIA-PACIFIC IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 81. ASIA-PACIFIC IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 82. ASIA-PACIFIC IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. CHINA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 84. CHINA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 85. CHINA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 86. CHINA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 87. JAPAN IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 88. JAPAN IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 89. JAPAN IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 90. JAPAN IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 91. INDIA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 92. INDIA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 93. INDIA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 94. INDIA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 95. SOUTH KOREA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 96. SOUTH KOREA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 97. SOUTH KOREA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 98. SOUTH KOREA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 99. AUSTRALIA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 100. AUSTRALIA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 101. AUSTRALIA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 102. AUSTRALIA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 103. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 104. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 105. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 106. REST OF ASIA-PACIFIC IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 107. LAMEA IMMUNOASSAY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 108. LAMEA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 109. LAMEA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 110. LAMEA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 111. LAMEA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 112. BRAZIL IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 113. BRAZIL IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 114. BRAZIL IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 115. BRAZIL IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 116. SOUTH AFRICA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 117. SOUTH AFRICA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 118. SOUTH AFRICA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 119. SOUTH AFRICA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 120. SAUDI ARABIA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 121. SAUDI ARABIA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 122. SAUDI ARABIA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 123. SAUDI ARABIA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 124. REST OF LAMEA IMMUNOASSAY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 125. REST OF LAMEA IMMUNOASSAY MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 126. REST OF LAMEA IMMUNOASSAY MARKET, BY SPECIMEN, 2024 - 2033 ($BILLION)
TABLE 127. REST OF LAMEA IMMUNOASSAY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 128. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 129. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 130. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 131. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 132. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 133. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 134. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 135. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 136. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 137. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 138. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 139. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 140. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 141. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 142. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143. SIEMENS HEALTHINEERS: KEY EXECUTIVES
TABLE 144. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 145. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 146. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 147. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 148. DIASORIN S.P.A.: KEY EXECUTIVES
TABLE 149. DIASORIN S.P.A.: COMPANY SNAPSHOT
TABLE 150. DIASORIN S.P.A.: OPERATING SEGMENTS
TABLE 151. DIASORIN S.P.A.: PRODUCT PORTFOLIO
TABLE 152. DIASORIN S.P.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 153. SYSMEX CORPORATION: KEY EXECUTIVES
TABLE 154. SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 155. SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 156. SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 157. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 158. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 159. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 160. BIOMERIEUX SA: OPERATING SEGMENTS
TABLE 161. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 162. BIOMERIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 163. ORTHO CLINICAL DIAGNOSTICS: KEY EXECUTIVES
TABLE 164. ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 165. ORTHO CLINICAL DIAGNOSTICS: OPERATING SEGMENTS
TABLE 166. ORTHO CLINICAL DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 167. ORTHO CLINICAL DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 168. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 169. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 170. THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 171. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 172. THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 173. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 174. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 175. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 176. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 177. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 178. MERCK KGAA: KEY EXECUTIVES
TABLE 179. MERCK KGAA: COMPANY SNAPSHOT
TABLE 180. MERCK KGAA: OPERATING SEGMENTS
TABLE 181. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 182. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL IMMUNOASSAY MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF IMMUNOASSAY MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN IMMUNOASSAY MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALIMMUNOASSAY MARKET
FIGURE 10. GLOBAL IMMUNOASSAY MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. IMMUNOASSAY MARKET FOR REAGENTS AND KITS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. IMMUNOASSAY MARKET FOR ANALYZERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL IMMUNOASSAY MARKET SEGMENTATION, BY TECHNOLOGY
FIGURE 14. IMMUNOASSAY MARKET FOR ELISA, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. IMMUNOASSAY MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. IMMUNOASSAY MARKET FOR IMMUNOFLUORESCENCE ASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. IMMUNOASSAY MARKET FOR RAPID TEST, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. IMMUNOASSAY MARKET FOR ELISPOT, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. IMMUNOASSAY MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. IMMUNOASSAY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. GLOBAL IMMUNOASSAY MARKET SEGMENTATION, BY SPECIMEN
FIGURE 22. IMMUNOASSAY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. IMMUNOASSAY MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. IMMUNOASSAY MARKET FOR ONCOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 25. IMMUNOASSAY MARKET FOR BONE AND MINERAL DISORDERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 26. IMMUNOASSAY MARKET FOR CARDIOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 27. IMMUNOASSAY MARKET FOR BLOOD SCREENING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 28. IMMUNOASSAY MARKET FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 29. IMMUNOASSAY MARKET FOR ALLERGY DIAGNOSTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 30. IMMUNOASSAY MARKET FOR TOXICOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 31. IMMUNOASSAY MARKET FOR NEWBORN SCREENING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 32. IMMUNOASSAY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 33. GLOBAL IMMUNOASSAY MARKET SEGMENTATION, BY END USER
FIGURE 34. IMMUNOASSAY MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 35. IMMUNOASSAY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 36. IMMUNOASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 37. IMMUNOASSAY MARKET FOR BLOOD BANKS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 38. IMMUNOASSAY MARKET FOR RESEARCH AND ACADEMIC LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 39. IMMUNOASSAY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: IMMUNOASSAY MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2023
FIGURE 47. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. DANAHER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. SIEMENS HEALTHINEERS: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. SIEMENS HEALTHINEERS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 59. DIASORIN S.P.A.: NET SALES, 2021-2023 ($BILLION)
FIGURE 60. DIASORIN S.P.A.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 61. DIASORIN S.P.A.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 62. SYSMEX CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 63. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 64. SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 65. BIOMERIEUX SA: NET SALES, 2021-2023 ($BILLION)
FIGURE 66. BIOMERIEUX SA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 67. BIOMERIEUX SA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 68. ORTHO CLINICAL DIAGNOSTICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 69. ORTHO CLINICAL DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 70. ORTHO CLINICAL DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 71. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 72. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 73. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 74. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
FIGURE 75. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 76. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 77. MERCK KGAA: NET SALES, 2021-2023 ($BILLION)
FIGURE 78. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 79. MERCK KGAA: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security